PFE R&D Expenses

Pfizer · R&D Expenses

PFE logo

PFE R&D Expenses

Latest reported$12.79B
PFE TTM R&D Expenses ($0.00 → $12.79B)
High-resolution chart · PNG

PFE r&d expenses history

Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.

Pfizer R&D Expenses — Trailing twelve months (TTM) (USD)
Period endingR&D Expenses (USD)
12,790,000,000
12,424,000,000
11,976,000,000
11,575,000,000
10,204,000,000
10,437,000,000
10,738,000,000
10,494,000,000
10,611,000,000
10,564,000,000
10,578,000,000
11,420,000,000
11,434,000,000
11,620,000,000
11,427,000,000
13,727,000,000
13,712,000,000
13,136,000,000
12,829,000,000
10,266,000,000
9,884,000,000
9,720,000,000
9,403,000,000
8,865,000,000
8,846,000,000
8,602,000,000
8,621,000,000
8,247,000,000
7,966,000,000
7,925,000,000
7,966,000,000
7,830,000,000
7,681,000,000
7,667,000,000
7,631,000,000
7,829,000,000
7,851,000,000
7,823,000,000
7,853,000,000
7,699,000,000
7,549,000,000
7,535,000,000
7,689,000,000
8,550,000,000
8,630,000,000
8,655,000,000
8,393,000,000
6,995,000,000
6,820,000,000
6,591,000,000
6,768,000,000
7,093,000,000
7,447,000,000
7,616,000,000
7,888,000,000
8,348,000,000
8,555,000,000
9,093,000,000
9,112,000,000
9,322,000,000
9,328,000,000
9,278,000,000
9,413,000,000
9,488,000,000
8,926,000,000
8,454,000,000
7,933,000,000
7,355,000,000
7,608,000,000
7,859,000,000
7,945,000,000
7,902,000,000
8,016,000,000
8,215,000,000
8,089,000,000
8,241,000,000
8,144,000,000
7,721,000,000
7,644,000,000
7,253,000,000
7,134,000,000
7,267,000,000
7,443,000,000
7,750,000,000
7,855,000,000
7,799,000,000
7,684,000,000
7,674,000,000
7,665,000,000
7,563,000,000
7,132,000,000
6,269,000,000
5,653,000,000
5,193,000,000
5,176,000,000
5,236,000,000
5,161,000,000
5,020,000,000
4,847,000,000
4,595,000,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.